SelectQuote 
SLQT is currently resting within my historical simple moving average zone. This often signals consolidation and a future move (in this case, let's hope up). Looking at the company's financials, SLQT is currently profitable. For Q3 2025 (ended March 31, 2025), the company reported a net income of $26.0 million, up from $8.6 million in Q3 2024. This follows a strong Q2 2025 with a net income of $53.2 million. While like most companies there are likely headwinds in 2025 (earnings are projected at a loss of -$0.20 per share due to seasonal fluctuations and investments in 2025 (e.g., new Kansas facility)), profitability is likely to stabilize in 2026, with EPS forecasts of $0.05, supported by improved Medicare reimbursement rates and operational efficiencies. Ongoing Department of Justice allegations could pose risks... but SelectQuote’s recent $350M investment and cost management suggest profitability may continue if legal issues are resolved favorably.
Thus, at $2.18,SLQT is in a personal buy zone. There is a potential for the price to dip to the bottom of the historical simple moving average channel (near $1.25) in the near-term, but time will tell.
Targets:
SLQT is currently resting within my historical simple moving average zone. This often signals consolidation and a future move (in this case, let's hope up). Looking at the company's financials, SLQT is currently profitable. For Q3 2025 (ended March 31, 2025), the company reported a net income of $26.0 million, up from $8.6 million in Q3 2024. This follows a strong Q2 2025 with a net income of $53.2 million. While like most companies there are likely headwinds in 2025 (earnings are projected at a loss of -$0.20 per share due to seasonal fluctuations and investments in 2025 (e.g., new Kansas facility)), profitability is likely to stabilize in 2026, with EPS forecasts of $0.05, supported by improved Medicare reimbursement rates and operational efficiencies. Ongoing Department of Justice allegations could pose risks... but SelectQuote’s recent $350M investment and cost management suggest profitability may continue if legal issues are resolved favorably.Thus, at $2.18,
SLQT is in a personal buy zone. There is a potential for the price to dip to the bottom of the historical simple moving average channel (near $1.25) in the near-term, but time will tell. Targets:
- $2.64
- $4.24
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。